Niki BioSolutions, Inc. (NIKI) Enterprise Value (2017 - 2025)

Niki BioSolutions' (NIKI) quarterly Enterprise Value came in at -$84890.0 in Q4 2025, down 199.83% on a QoQ basis from -$28313.0 in Q3 2025.

Niki BioSolutions, Inc. (NIKI) Enterprise Value (2017 - 2025) Analysis & Trends

Niki BioSolutions (NIKI) has 9 years of Enterprise Value data on file, last reported at -$84890.0 in Q4 2025.

Quarterly Enterprise Value changed N/A year-over-year to -$84890.0 in Q4 2025, while the trailing twelve-month figure through Nov 2025 was -$84890.0 (changed N/A YoY) and the FY2025 annual result came in at -$12.8 million, down 12.81% from the prior year.
Enterprise Value slipped to -$84890.0 in Q4 2025, from -$28313.0 in the prior quarter.
In the past five years, Enterprise Value ranged from a high of -$28313.0 in Q3 2025 to a low of -$25.8 million in Q2 2021.
A 5-year average of -$9.3 million and a median of -$11.4 million in 2022 frame the typical range for Enterprise Value.
The widest YoY moves for Enterprise Value: up 59.39% in 2021, down 282.76% in 2021.
Tracing NIKI's Enterprise Value over 5 years: stood at -$14.5 million in 2021, then slipped by 10.55% to -$16.0 million in 2022, then grew by 27.78% to -$11.6 million in 2023, then soared by 99.39% to -$70276.0 in 2024, then fell by 20.8% to -$84890.0 in 2025.
The last three Enterprise Value figures came in at -$84890.0 (Q4 2025), -$28313.0 (Q3 2025), and -$56836.0 (Q2 2025), per Business Quant data.

Download Data